SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- obesity/erectile dysfunction
An SI Board Since February 2001
Posts SubjectMarks Bans
435 30 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10Monday March 19, 7:31 pm Eastern Time Eli Lilly releases positive data on anti-scaram(o)uche-3/19/2001
9Wednesday March 14, 6:46 pm Eastern Time Press Release ON24 Video Investor Alescaram(o)uche-3/14/2001
8webmd-practice.medcast.comscaram(o)uche-2/13/2001
7Nat Genet 2000 May;25(1):102-4 Dopamine is required for scaram(o)uche-2/8/2001
6Oh Please Dear. Expand on the subject.10K a day-2/8/2001
5Thursday January 25, 6:52 pm Eastern Time Abbott says European committee positiscaram(o)uche-2/8/2001
4I believe that Ixense (Takeda, previous post) is sublingual apomorphine, licensescaram(o)uche-2/8/2001
3Friday January 26, 1:03 am Eastern Time Takeda's new ED drug near approval scaram(o)uche-2/8/2001
2Monday February 5, 6:45 pm Eastern Time Press Release SOURCE: GENSET Publicatscaram(o)uche-2/8/2001
1melanotan....... foxnews.com Int J Impot Res 2000 Oct;12 Suppl 4:S74-9 scaram(o)uche-2/5/2001
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News